These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 22267972

  • 1. Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression.
    Gangemi R, Mirisola V, Barisione G, Fabbi M, Brizzolara A, Lanza F, Mosci C, Salvi S, Gualco M, Truini M, Angelini G, Boccardo S, Cilli M, Airoldi I, Queirolo P, Jager MJ, Daga A, Pfeffer U, Ferrini S.
    PLoS One; 2012; 7(1):e29989. PubMed ID: 22267972
    [Abstract] [Full Text] [Related]

  • 2. Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis.
    Das SK, Guo C, Pradhan AK, Bhoopathi P, Talukdar S, Shen XN, Emdad L, Subler MA, Windle JJ, Sarkar D, Wang XY, Fisher PB.
    Oncotarget; 2016 Jul 26; 7(30):46848-46861. PubMed ID: 27341128
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin.
    Kegelman TP, Wu B, Das SK, Talukdar S, Beckta JM, Hu B, Emdad L, Valerie K, Sarkar D, Furnari FB, Cavenee WK, Wei J, Purves A, De SK, Pellecchia M, Fisher PB.
    Proc Natl Acad Sci U S A; 2017 Jan 10; 114(2):370-375. PubMed ID: 28011764
    [Abstract] [Full Text] [Related]

  • 4. The MDA-9/Syntenin/IGF1R/STAT3 Axis Directs Prostate Cancer Invasion.
    Das SK, Pradhan AK, Bhoopathi P, Talukdar S, Shen XN, Sarkar D, Emdad L, Fisher PB.
    Cancer Res; 2018 Jun 01; 78(11):2852-2863. PubMed ID: 29572229
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. RETRACTED: mda-9/Syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-kappaB.
    Boukerche H, Su ZZ, Emdad L, Sarkar D, Fisher PB.
    Cancer Res; 2007 Feb 15; 67(4):1812-22. PubMed ID: 17308124
    [Abstract] [Full Text] [Related]

  • 7. MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer.
    Menezes ME, Shen XN, Das SK, Emdad L, Sarkar D, Fisher PB.
    Oncotarget; 2016 Dec 06; 7(49):80175-80189. PubMed ID: 27863394
    [Abstract] [Full Text] [Related]

  • 8. Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kappaB.
    Boukerche H, Aissaoui H, Prévost C, Hirbec H, Das SK, Su ZZ, Sarkar D, Fisher PB.
    Oncogene; 2010 May 27; 29(21):3054-66. PubMed ID: 20228839
    [Abstract] [Full Text] [Related]

  • 9. MDA-9/syntenin is a key regulator of glioma pathogenesis.
    Kegelman TP, Das SK, Hu B, Bacolod MD, Fuller CE, Menezes ME, Emdad L, Dasgupta S, Baldwin AS, Bruce JN, Dent P, Pellecchia M, Sarkar D, Fisher PB.
    Neuro Oncol; 2014 Jan 27; 16(1):50-61. PubMed ID: 24305713
    [Abstract] [Full Text] [Related]

  • 10. Novel role of MDA-9/syntenin in regulating urothelial cell proliferation by modulating EGFR signaling.
    Dasgupta S, Menezes ME, Das SK, Emdad L, Janjic A, Bhatia S, Mukhopadhyay ND, Shao C, Sarkar D, Fisher PB.
    Clin Cancer Res; 2013 Sep 01; 19(17):4621-33. PubMed ID: 23873690
    [Abstract] [Full Text] [Related]

  • 11. Crizotinib, a c-Met inhibitor, prevents metastasis in a metastatic uveal melanoma model.
    Surriga O, Rajasekhar VK, Ambrosini G, Dogan Y, Huang R, Schwartz GK.
    Mol Cancer Ther; 2013 Dec 01; 12(12):2817-26. PubMed ID: 24140933
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. MDA-9/syntenin and IGFBP-2 promote angiogenesis in human melanoma.
    Das SK, Bhutia SK, Azab B, Kegelman TP, Peachy L, Santhekadur PK, Dasgupta S, Dash R, Dent P, Grant S, Emdad L, Pellecchia M, Sarkar D, Fisher PB.
    Cancer Res; 2013 Jan 15; 73(2):844-54. PubMed ID: 23233738
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MDA-9/Syntenin/SDCBP: new insights into a unique multifunctional scaffold protein.
    Pradhan AK, Maji S, Das SK, Emdad L, Sarkar D, Fisher PB.
    Cancer Metastasis Rev; 2020 Sep 15; 39(3):769-781. PubMed ID: 32410111
    [Abstract] [Full Text] [Related]

  • 16. mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src.
    Boukerche H, Su ZZ, Prévot C, Sarkar D, Fisher PB.
    Proc Natl Acad Sci U S A; 2008 Oct 14; 105(41):15914-9. PubMed ID: 18832467
    [Abstract] [Full Text] [Related]

  • 17. mda-9/Syntenin: a positive regulator of melanoma metastasis.
    Boukerche H, Su ZZ, Emdad L, Baril P, Balme B, Thomas L, Randolph A, Valerie K, Sarkar D, Fisher PB.
    Cancer Res; 2005 Dec 01; 65(23):10901-11. PubMed ID: 16322237
    [Abstract] [Full Text] [Related]

  • 18. MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis.
    Das SK, Maji S, Wechman SL, Bhoopathi P, Pradhan AK, Talukdar S, Sarkar D, Landry J, Guo C, Wang XY, Cavenee WK, Emdad L, Fisher PB.
    Pharmacol Res; 2020 May 01; 155():104695. PubMed ID: 32061839
    [Abstract] [Full Text] [Related]

  • 19. Raf kinase inhibitor RKIP inhibits MDA-9/syntenin-mediated metastasis in melanoma.
    Das SK, Bhutia SK, Sokhi UK, Azab B, Su ZZ, Boukerche H, Anwar T, Moen EL, Chatterjee D, Pellecchia M, Sarkar D, Fisher PB.
    Cancer Res; 2012 Dec 01; 72(23):6217-26. PubMed ID: 23066033
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1β.
    Pradhan AK, Maji S, Bhoopathi P, Talukdar S, Mannangatti P, Guo C, Wang XY, Cartagena LC, Idowu M, Landry JW, Sarkar D, Emdad L, Cavenee WK, Das SK, Fisher PB.
    Proc Natl Acad Sci U S A; 2021 May 25; 118(21):. PubMed ID: 34016751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.